High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel

被引:17
作者
Abali, H [1 ]
Çelik, I [1 ]
机构
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2002年 / 25卷 / 06期
关键词
D O I
10.1097/00000421-200212000-00023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:632 / 633
页数:2
相关论文
共 6 条
  • [1] Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors:: 5-year follow-up results of French adjuvant study group 05 randomized trial
    Adenis, A
    Bonneterre, J
    Bonneterre, ME
    Pion, JM
    Vanlemmens, L
    Gladieff, L
    de Lafontan, B
    Martel, P
    Mihura, J
    Roché, H
    Gédouin, D
    Kerbrat, P
    Lesimple, T
    Brémond, A
    Devaux, Y
    Delecroix, V
    Fumoleau, P
    Maugard-Louboutin, C
    Namer, M
    Goudier, MJ
    Morice, F
    Montcuquet, P
    Schraub, S
    Coudert, B
    Fargeot, P
    de Gislain, C
    Mayer, F
    Bastit, P
    Chevallier, B
    Grandgirard, A
    Monnier, A
    Sun, X
    Clavère, P
    Ollivier, JP
    Rhein, B
    Roullet, B
    Datchary, J
    Audhuy, B
    Barats, JC
    Kohser, F
    Dides, S
    Ramos, R
    Cattan, A
    Eymard, JC
    Pourny, C
    Weber, B
    de Laroche, G
    Pichon, A
    Seffert, P
    Hayat, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) : 602 - 611
  • [2] ARNDT CAS, 1988, CANCER RES, V48, P2113
  • [3] High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
    Crivellari, D
    Pagani, O
    Veronesi, A
    Lombardi, D
    Nolè, F
    Thürlimann, B
    Hess, D
    Borner, M
    Bauer, J
    Martinelli, G
    Graffeo, R
    Sessa, C
    Goldhirsch, A
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (03) : 353 - 356
  • [4] The taxanes: an update
    Crown, J
    O'Leary, M
    [J]. LANCET, 2000, 355 (9210) : 1176 - 1178
  • [5] TSUKADA Y, 1983, CANCER-AM CANCER SOC, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO
  • [6] 2-B